Multicenter validation of CEACAM6 and FOXP3 as robust prognostic biomarkers in colon cancer: Combined immunohistochemical and transcriptomic analysis. - Liu, Yingying; Ye, Jianxin; Ma, Jinzhao; Pan, Xingxiao (Molecular & Clinical Oncology, 2025)